📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-12 17:57
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Dev Labtech to Raise ₹17.81 Cr via Convertible Warrants; EGM on Nov 5
Dev Labtech Venture Limited has issued an EGM notice for November 5, 2026, to approve a preferential issue of up to 1.37 crore convertible warrants at ₹13 each, aggregating to ₹17.81 crore. The warrants will be allotted to promoter and non-promoter entities, with promoters receiving 1.08 crore warrants. The fundraise represents approximately 22% of the company's current market cap of ₹81 crore and 40.5% of its net worth (₹44 crore). Additionally, the company seeks shareholder approval to increase its authorized share capital from ₹25 crore to ₹31 crore.
Confidence: HIGH
What changedDev Labtech called an EGM to approve an authorized capital hike and issue 1.37 crore convertible warrants to raise ₹17.81 crore.
Why it mattersThe fundraise injects ₹17.81 crore of fresh equity over 18 months, representing 22% of market cap, but will dilute existing equity holders at a issue price (₹13) below the current market price (₹18.7).
Total Fundraise Value: Rs. 17,81,00,000/-Fundraise vs Market Cap: ~22.0%Warrants Proposed: 1,37,00,000Issue Price per Warrant: Rs. 13/-EGM Date: 5th November, 2026
📅 Short termShareholders will monitor voting results on November 5, 2026, and receipt of 25% upfront warrant subscription money.
📈 Long termIf converted within 18 months, the capital will strengthen the balance sheet and net worth, but causes notable equity dilution.
⚠ Risk flags
- Equity dilution of up to 1.37 crore shares
- Issue price of ₹13 is below current market price of ₹18.7
- Warrant holders have up to 18 months to exercise conversion
Key Highlights
Proposed preferential issue of 1,37,00,000 convertible warrants at ₹13 per warrant aggregating to ₹17.81 crore
Issue price of ₹13 represents a discount to the current market price of ₹18.7
Promoters/Promoter Group to be allocated 1,07,92,000 warrants (78.8% of the issue)
Authorized share capital proposed to increase from ₹25.00 crore to ₹31.00 crore
EGM scheduled for Thursday, November 5, 2026 at 1:00 PM via VC/OAVM
👀 What to Watch
Track the outcome of shareholder voting at the EGM on November 5, 2026, followed by in-principle approval from BSE and subsequent conversion timelines within the 18-month window.
Dev Labtech to Raise ₹17.81 Cr via 1.37 Cr Convertible Warrants at ₹13/Share
Dev Labtech Venture Ltd's board approved the preferential issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, aggregating to ₹17.81 crore. The warrants are being issued to promoters and non-promoter investors, with promoter holding slated to rise to 61.64% from 56.69% post-conversion. The warrant price of ₹13 represents a discount to the current market price of ₹18.7. To facilitate this, the board also approved increasing the authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM on November 5, 2026.
Confidence: HIGH
What changedThe board approved a preferential issue of 1.37 crore convertible warrants to raise ₹17.81 crore and proposed increasing authorized capital.
Why it mattersThe fundraise equals ~22% of Dev Labtech's current market cap of ₹81 crore and ~40% of its net worth, providing growth capital while diluting existing public shareholders at an issue price below the market price.
Total fundraise amount: Rs. 17,81,00,000/-Issue price per warrant: Rs. 13/-Fundraise vs Market Cap: ~22%Total warrants issued: 1,37,00,000Post-issue promoter holding: 61.64%
📅 Short termMarket may digest the warrant issue price of ₹13, which is below the current trading price of ₹18.7, ahead of the November 5, 2026 EGM vote.
📈 Long termUpon full conversion within 18 months, the company's net worth will strengthen with an inflow of ₹17.81 crore, supporting balance sheet expansion, though equity base dilution will occur.
⚠ Risk flags
- Issue price (₹13) is priced at a discount to the prevailing market price (~₹18.7)
- Equity dilution of minority shareholders as promoters increase holding to 61.64%
Key Highlights
Issuance of up to 1,37,00,000 convertible warrants at ₹13 each (aggregating ₹17,81,00,000)
Post-conversion promoter shareholding will increase to 61.64% (from 56.69%), while non-promoters will hold 38.36%
Authorized share capital increased from ₹25,00,00,000 (5 crore shares) to ₹31,00,00,000 (6.2 crore shares)
Warrant tenor is 18 months, exercisable into equity shares of face value ₹5 at a ₹8 premium
EGM scheduled for November 5, 2026 with a voting cut-off date of October 29, 2026
👀 What to Watch
Track shareholder approval at the EGM on November 5, 2026, and monitor regulatory approvals alongside the timeline for upfront warrant subscription (25% cash inflow).
Dev Labtech to Raise ₹17.81 Cr via 1.37 Cr Convertible Warrants at ₹13/Share
Dev Labtech Venture Ltd's board approved the preferential issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, aggregating to ₹17.81 crore. The warrants are being issued to promoters and non-promoter investors, with promoter holding slated to rise to 61.64% from 56.69% post-conversion. The warrant price of ₹13 represents a discount to the current market price of ₹18.7. To facilitate this, the board also approved increasing the authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM on November 5, 2026.
Confidence: HIGH
What changedThe board approved a preferential issue of 1.37 crore convertible warrants to raise ₹17.81 crore and proposed increasing authorized capital.
Why it mattersThe fundraise equals ~22% of Dev Labtech's current market cap of ₹81 crore and ~40% of its net worth, providing growth capital while diluting existing public shareholders at an issue price below the market price.
Total fundraise amount: Rs. 17,81,00,000/-Issue price per warrant: Rs. 13/-Fundraise vs Market Cap: ~22%Total warrants issued: 1,37,00,000Post-issue promoter holding: 61.64%
📅 Short termMarket may digest the warrant issue price of ₹13, which is below the current trading price of ₹18.7, ahead of the November 5, 2026 EGM vote.
📈 Long termUpon full conversion within 18 months, the company's net worth will strengthen with an inflow of ₹17.81 crore, supporting balance sheet expansion, though equity base dilution will occur.
⚠ Risk flags
- Issue price (₹13) is priced at a discount to the prevailing market price (~₹18.7)
- Equity dilution of minority shareholders as promoters increase holding to 61.64%
Key Highlights
Issuance of up to 1,37,00,000 convertible warrants at ₹13 each (aggregating ₹17,81,00,000)
Post-conversion promoter shareholding will increase to 61.64% (from 56.69%), while non-promoters will hold 38.36%
Authorized share capital increased from ₹25,00,00,000 (5 crore shares) to ₹31,00,00,000 (6.2 crore shares)
Warrant tenor is 18 months, exercisable into equity shares of face value ₹5 at a ₹8 premium
EGM scheduled for November 5, 2026 with a voting cut-off date of October 29, 2026
👀 What to Watch
Track shareholder approval at the EGM on November 5, 2026, and monitor regulatory approvals alongside the timeline for upfront warrant subscription (25% cash inflow).
Dev Labtech to Raise ₹17.81 Cr via 1.37 Cr Convertible Warrants at ₹13/Share
Dev Labtech Venture Ltd's board approved the preferential issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, aggregating to ₹17.81 crore. The warrants are being issued to promoters and non-promoter investors, with promoter holding slated to rise to 61.64% from 56.69% post-conversion. The warrant price of ₹13 represents a discount to the current market price of ₹18.7. To facilitate this, the board also approved increasing the authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM on November 5, 2026.
Confidence: HIGH
What changedThe board approved a preferential issue of 1.37 crore convertible warrants to raise ₹17.81 crore and proposed increasing authorized capital.
Why it mattersThe fundraise equals ~22% of Dev Labtech's current market cap of ₹81 crore and ~40% of its net worth, providing growth capital while diluting existing public shareholders at an issue price below the market price.
Total fundraise amount: Rs. 17,81,00,000/-Issue price per warrant: Rs. 13/-Fundraise vs Market Cap: ~22%Total warrants issued: 1,37,00,000Post-issue promoter holding: 61.64%
📅 Short termMarket may digest the warrant issue price of ₹13, which is below the current trading price of ₹18.7, ahead of the November 5, 2026 EGM vote.
📈 Long termUpon full conversion within 18 months, the company's net worth will strengthen with an inflow of ₹17.81 crore, supporting balance sheet expansion, though equity base dilution will occur.
⚠ Risk flags
- Issue price (₹13) is priced at a discount to the prevailing market price (~₹18.7)
- Equity dilution of minority shareholders as promoters increase holding to 61.64%
Key Highlights
Issuance of up to 1,37,00,000 convertible warrants at ₹13 each (aggregating ₹17,81,00,000)
Post-conversion promoter shareholding will increase to 61.64% (from 56.69%), while non-promoters will hold 38.36%
Authorized share capital increased from ₹25,00,00,000 (5 crore shares) to ₹31,00,00,000 (6.2 crore shares)
Warrant tenor is 18 months, exercisable into equity shares of face value ₹5 at a ₹8 premium
EGM scheduled for November 5, 2026 with a voting cut-off date of October 29, 2026
👀 What to Watch
Track shareholder approval at the EGM on November 5, 2026, and monitor regulatory approvals alongside the timeline for upfront warrant subscription (25% cash inflow).
Dev Labtech to Raise ₹17.81 Cr via 1.37 Cr Convertible Warrants at ₹13/Share
Dev Labtech Venture Ltd's board approved the preferential issuance of up to 1.37 crore convertible warrants at ₹13 per warrant, aggregating to ₹17.81 crore. The warrants are being issued to promoters and non-promoter investors, with promoter holding slated to rise to 61.64% from 56.69% post-conversion. The warrant price of ₹13 represents a discount to the current market price of ₹18.7. To facilitate this, the board also approved increasing the authorized share capital from ₹25 crore to ₹31 crore, subject to shareholder approval at an EGM on November 5, 2026.
Confidence: HIGH
What changedThe board approved a preferential issue of 1.37 crore convertible warrants to raise ₹17.81 crore and proposed increasing authorized capital.
Why it mattersThe fundraise equals ~22% of Dev Labtech's current market cap of ₹81 crore and ~40% of its net worth, providing growth capital while diluting existing public shareholders at an issue price below the market price.
Total fundraise amount: Rs. 17,81,00,000/-Issue price per warrant: Rs. 13/-Fundraise vs Market Cap: ~22%Total warrants issued: 1,37,00,000Post-issue promoter holding: 61.64%
📅 Short termMarket may digest the warrant issue price of ₹13, which is below the current trading price of ₹18.7, ahead of the November 5, 2026 EGM vote.
📈 Long termUpon full conversion within 18 months, the company's net worth will strengthen with an inflow of ₹17.81 crore, supporting balance sheet expansion, though equity base dilution will occur.
⚠ Risk flags
- Issue price (₹13) is priced at a discount to the prevailing market price (~₹18.7)
- Equity dilution of minority shareholders as promoters increase holding to 61.64%
Key Highlights
Issuance of up to 1,37,00,000 convertible warrants at ₹13 each (aggregating ₹17,81,00,000)
Post-conversion promoter shareholding will increase to 61.64% (from 56.69%), while non-promoters will hold 38.36%
Authorized share capital increased from ₹25,00,00,000 (5 crore shares) to ₹31,00,00,000 (6.2 crore shares)
Warrant tenor is 18 months, exercisable into equity shares of face value ₹5 at a ₹8 premium
EGM scheduled for November 5, 2026 with a voting cut-off date of October 29, 2026
👀 What to Watch
Track shareholder approval at the EGM on November 5, 2026, and monitor regulatory approvals alongside the timeline for upfront warrant subscription (25% cash inflow).
